These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6402001)

  • 1. Biological classification of depressive illness.
    Coppen A; Wood K
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):161S-164S. PubMed ID: 6402001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine responses after thyrotrophin-releasing hormone stimulation and dexamethasone suppression tests in the major depressive syndrome.
    Aalbers C; Taljaard JJ; Gagiano CA
    S Afr Med J; 1986 Oct; 70(8):464-8. PubMed ID: 3095937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyrotropin-releasing hormone in psychiatry: marker, predictor and therapeutical tool].
    Babinski T; Paunović VR
    Srp Arh Celok Lek; 1994; 122(11-12):341-3. PubMed ID: 17974414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative psychopathology of depression: application of the Newcastle Scale].
    Staner L
    Acta Psychiatr Belg; 1994; 94(1):23-39. PubMed ID: 7502647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological markers of melancholia and reclassification of depressive disorders.
    Greden JF
    Encephale; 1982; 8(2):193-202. PubMed ID: 6809444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtypes in major depression without melancholia.
    Gagiano CA; Fourie J; Müller FG; Vermaak WJ
    S Afr Med J; 1988 Aug; 74(3):106-8. PubMed ID: 3135603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DST and TRH stimulation test in mood disorder subtypes.
    Levy AB; Stern SL
    Am J Psychiatry; 1987 Apr; 144(4):472-5. PubMed ID: 3105335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine changes in depression.
    Joyce PR
    Aust N Z J Psychiatry; 1985 Jun; 19(2):120-7. PubMed ID: 2413836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The dexamethasone suppression test and TRH stimulation test in endogenous depressives, schizophrenics, and normal volunteers].
    Ho SL; Lu RB; Ferng HK; Lin TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Apr; 41(4):271-80. PubMed ID: 3141027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H; Moron P
    Encephale; 1983; 9(1):1-22. PubMed ID: 6135596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
    NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder.
    Isogawa K; Nagayama H; Tsutsumi T; Kiyota A; Akiyoshi J; Hieda K
    J Psychiatr Res; 2005 Sep; 39(5):467-73. PubMed ID: 15992555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objectifying psychiatric diagnosis and treatment with the dexamethasone suppression test.
    Pollock DC; Sheehan ME
    J Fam Pract; 1982 Oct; 15(4):641-5. PubMed ID: 6288832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antidepressant treatment with clomipramine on hormonal responses to thyrotropin-releasing hormone and insulin-induced hypoglycemia: implications for the "monoamine-hypothesis".
    Langer G; Karobath M; Sieghart W; Aschauer H; Placheta P; Spona J
    Pharmacopsychiatria; 1981 May; 14(3):100-6. PubMed ID: 6789342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.